Mind Medicine (MindMed) Ownership | Who Owns Mind Medicine (MindMed)?


OverviewFinancialsChartTranscripts

Mind Medicine (MindMed) Ownership Summary


Mind Medicine (MindMed) is owned by 48.94% institutional investors, 0.84% insiders, and 50.22% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 6.80% of MNMD shares. iShares Russell 2000 ETF is the top mutual fund, with 2.36% of its assets in Mind Medicine (MindMed) shares.

MNMD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMind Medicine (MindMed)48.94%0.84%50.22%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%
IdeaPsychedelic Stocks List41.93%14.87%43.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de5.80M6.80%$37.66M
Blackstone3.59M4.20%$23.28M
Marshall wace, llp3.42M4.01%$22.20M
Driehaus capital management3.09M3.62%$20.07M
Deep track capital, lp2.50M2.93%$16.23M
Awm investment company1.22M1.42%$7.89M
Ally bridge group (ny)726.17K0.85%$4.71M
Tang capital management600.20K0.70%$3.90M
Advisorshares investments109.59K0.13%$711.26K
Data collective iv gp100.35K0.12%$651.27K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ally bridge group (ny)726.17K3.92%$4.71M
Caxton34.07K2.24%$221.13K
Awm investment company1.22M0.88%$7.89M
Deep track capital, lp2.50M0.52%$16.23M
Data collective iv gp100.35K0.50%$651.27K
Tang capital management600.20K0.20%$3.90M
Stempoint capital lp90.85K0.19%$589.63K
Driehaus capital management3.09M0.16%$20.07M
Advisorshares investments109.59K0.13%$711.26K
Blackstone3.59M0.10%$23.28M

Top Buyers

HolderShares% AssetsChange
Marshall wace, llp3.42M0.03%828.07K
Ally bridge group (ny)726.17K3.92%336.03K
Tang capital management600.20K0.20%200.00K
Stempoint capital lp90.85K0.19%90.85K
Blackrock funding, inc. /de5.80M0.00%86.43K

Top Sellers

HolderShares% AssetsChange
Tri locum partners lp---820.79K
Driehaus capital management3.09M0.16%-258.75K
Millennium management---185.72K
Balyasny asset management38.94K0.00%-130.62K
Allostery investments lp---130.00K

New Positions

HolderShares% AssetsChangeValue
Stempoint capital lp90.85K0.19%90.85K$589.63K
Polar asset management partners29.30K0.00%29.30K$190.16K
Exoduspoint capital management, lp17.88K0.00%17.88K$116.00K
Dynamic technology lab private14.62K0.01%14.62K$95.00K
Gotham asset management14.08K0.00%14.08K$91.37K

Sold Out

HolderChange
Coppell advisory solutions-1.00
Hexagon capital partners-4.00
Glen eagle advisors-6.00
Svb wealth-11.00
Harbor investment advisory-13.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025186-5.58%41,767,7331.94%482.11%77-15.38%484.35%
Mar 31, 20252009.89%41,145,735-1.08%481.97%91-6.19%4742.42%
Dec 31, 20241-1-------
Sep 30, 20241-1-------
Jun 30, 20241-1-------

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Russell 2000 ETF1.79M2.36%-34.13K
Fidelity Small Cap Index757.61K1.00%10.84K
Vanguard Institutional Extnd Mkt Idx Tr734.70K0.97%-319.00K
Heptagon Driehaus US Micro Cap Eq C$ Acc702.75K0.92%39.57K
Nuveen Quant Small Cap Equity R6523.40K0.69%523.40K
iShares Russell 2000 Value ETF446.63K0.59%331.00
State St Russell Sm/Mid Cp® Indx NL Cl C438.11K0.58%1.81K
State St Russell Sm/Mid Cp® Indx SL Cl I433.91K0.57%-
Fidelity Extended Market Index360.22K0.48%-940.00
Vanguard Russell 2000 ETF359.09K0.47%-24.48K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 25, 2025Sullivan Mark Chief Legal OfficerSell$78.14K
Jun 25, 2025Karlin Daniel Chief Medical OfficerSell$53.37K
Jun 25, 2025Barrow Robert Chief Executive OfficerSell$180.14K
Mar 25, 2025Barrow Robert Chief Executive OfficerSell$142.94K
Mar 25, 2025Karlin Daniel Chief Medical OfficerSell$46.07K

Insider Transactions Trends


DateBuySell
2025 Q2-3
2025 Q1-4
2024 Q414
2024 Q334
2024 Q2-3

MNMD Ownership FAQ


Who Owns Mind Medicine (MindMed)?

Mind Medicine (MindMed) shareholders are primarily institutional investors at 48.94%, followed by 0.84% insiders and 50.22% retail investors. The average institutional ownership in Mind Medicine (MindMed)'s industry, Biotech Stocks , is 306.59%, which Mind Medicine (MindMed) falls below.

Who owns the most shares of Mind Medicine (MindMed)?

Mind Medicine (MindMed)’s largest shareholders are Blackrock funding, inc. /de (5.8M shares, 6.80%), Blackstone (3.59M shares, 4.20%), and Marshall wace, llp (3.42M shares, 4.01%). Together, they hold 15.01% of Mind Medicine (MindMed)’s total shares outstanding.

Does Blackrock own Mind Medicine (MindMed)?

BlackRock is not among the top 10 institutional shareholders of Mind Medicine (MindMed).

Who is Mind Medicine (MindMed)’s biggest shareholder by percentage of total assets invested?

Ally bridge group (ny) is Mind Medicine (MindMed)’s biggest shareholder by percentage of total assets invested, with 3.92% of its assets in 726.17K Mind Medicine (MindMed) shares, valued at 4.71M$.

Who is the top mutual fund holder of Mind Medicine (MindMed) shares?

iShares Russell 2000 ETF is the top mutual fund holder of Mind Medicine (MindMed) shares, with 2.36% of its total shares outstanding invested in 1.79M Mind Medicine (MindMed) shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools